ProCTi helps pharmaceutical manufacturers become more competitive in a rapidly evolving market characterized by unpredictable product pipelines and uncertain regulatory actions. We bring unmatched expertise in innovation, cost management, organizational design, M&A and other disciplines that determine which pharma companies achieve and maintain industry leadership.
Amgen is one of the world’s leading biotechnology companies. With revenues of $22.8 billion.
In March 2016, one of the main Private Equity funds of the world, the American HIG Capital, became part of the Halexistar Group. With more than $ 20 billion of capital under its worldwide management, the H.I.G. added to this success story.